Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer - Concepedia

Concepedia

Publication | Open Access

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer

DOI Full Paper Access

21

Citations

10

References

2022

Year

Arlene Chan, Manuel Ruíz‐Borrego, Gavin Marx, A. Jo Chien, Hope S. Rugo, Adam Brufsky, Michael P. Thirlwell, Maureen Trudeau, Ron Bose, José Á. García-Sáenz,

Abstract

NCT02400476.

References

	Year	Citations

Page 1